Other Publication
Preevent
 

Future Supply Chain Strategies

 

Date: 14 - 16 July 2010
Venue: The Golden Palms Hotel & Spa, Bangaluru, India
Website: http://www.frost.com/prod/servlet/summits-details.pag?eventid=196061111

Event Background

India's ascending fortunes in the manufacturing sector over the last few years have opened several opportunity windows for the logistics market. This trend is likely to gain pace as the global economic slowdown gradually recedes and India emerges as one of the earliest major economies to recover from this recession. This fast-paced growth of the industrial sector, coupled with the more sturdy progress of the agricultural sector, has necessitated extensive supply chains across the country to facilitate sourcing and distribution of production.
Frost & Sullivan finds that the total logistics market in India earned revenues of $75.19 billion in 2009, representing about 6.2 percent of the country's GDP. The market is expected to reach $120.42 billion in 2014, witnessing a CAGR of 9.9 percent between 2009 and 2014. Transportation segment accounts for close to 62.0 percent of the total market reiterating the fact that it is the most important logistics function for all industries. Further, agricultural sector accounts for slightly over half of the total logistics market in India, owing to the extensive storage and transportation activities associated with agro products within the country.
However, Indian logistics service providers (LSPs) lag significantly below end-user expectations on key performance criteria such as attitude of staff, process improvement capabilities and material safety. The performance benchmarking of Indian LSPs, which is based on the ratings provided by leading end users from eight key industry sectors in the country revealed that LSPs performed well above user expectations on a few key parameters such as fleet size, vehicle quality, number of warehouses, and warehouse size. With regard to aspects such as value addition, consignment tracking facility, and cost saving initiatives, LSP performance came close to end-user expectations. Inability of LSPs to keep pace with evolving volumes of end users and the lack of multimodal transpiration capabilities are other impediments and concerns the end users are facing
Frost & Sullivan's Initiative to Develop Future Supply Chain Strategies
Keeping in perspective the challenges faced by the Logistics Service Providers (LSP's) and End Users, Frost & Sullivan's Transportation and Logistics Practice is organizing an exclusive strategy workshop 'Future Supply Chain Strategies'.
The workshop intends to ensemble a network of today's best thinkers, visionaries and thought leaders, from across key industry sectors such as Automotive, IT Hardware & Telecom Equipment, Retail and Pharmaceuticals in India, for a specific and definite purpose of developing future supply chain strategies. In this endeavor, Frost & Sullivan will facilitate the participants to ideate and evaluate best possible methods and practices through workshops, breakout sessions and panel discussions to develop practical, feasible and sustainable supply chain models essential for organizations.
Advantages of Participating in the Workshop
  • This workshop provides deep know-how in deploying, managing, and optimizing logistics challenges improving performance, increasing availability, reducing implementation time and meeting expectations of end-users which is a critical business challenge
  • This platform will provide insights and specific tools for actionable strategies for future supply chain issues faced by stakeholders in supply chains (logistics service providers and users) within the key industry sectors
  • Interact with representatives from end-user industries presenting their views on the current status and path ahead for supply chains of their respective industries
  • Mutual evaluation and collective effort to arrive at the most appropriate supply chain strategies to meet future needs
Visitor Profile:
Leading Companies from the Key Industry Sectors like
  • Automotive
  • IT Hardware & Telecom Equipment
  • Pharmaceuticals
  • Retail
Leading Providers of Logistics Infrastructure in India like
  • Operators of Airports and Seaports,
  • Owners of Logistics Parks and Free Trade Warehousing Zones
  • Operators of Inland Container Depots and Container Freight Stations
  • Material Handling Equipment Providers
  • Supply Chain Technology Solutions Providers
  • Investors

Workshop on Biosimilars

Date:23 July 2010
Venue:Bangalore, Karnataka, India
Website:http://www.iprconference.com
Organizer:ITAG Business Solutions Ltd
ITAG is organizing one-day workshop on Biosimilar Patenting in collaboration with its knowledge partner Sughrue Mion PLLC, USA in Bangalore and Hyderabad. This event will be a platform for emerging opportunities for Biosimilars in the Global Market.
Biosimilars are of tremendous interest globally. It has been predicted that in the near future biologic therapies will amount to more than 50% of newly approved medicines. In the same period, a substantial number of patent protected biotechnology-based therapies will come off patent, enabling the marketing of biosimilar or follow on biologic products. Even though opportunities abound, biosimilar producers and patients face risks, requiring producers to develop innovative legal strategies and to carefully assess research and development and production processes to guarantee safety and efficacy of biosimilar products to establish an efficient and safe strategy for biosimilar approval
This workshop will explore and analyze the new US Biosimilar Pathway including comparative analysis of the US Pathway and pathways in other countries, including the Indian perspective in this regard
Biosimilars are of incredible attention globally in the fastest growing sectors of the pharmaceutical industry. As major therapeutic biological products currently on the market approach the expiration of patent, drug manufacturers around the world are exploring the possibility of producing "generic" biopharmaceuticals - known as "Biosimilars" - that would increase the availability and lower the price of these life-saving products worldwide. US governance aims to set up specific guidelines for Biosimilars (F.O.B: Follow On Biologic): this new scenario provides opportunities for companies considering biosimilars as a priority for growing in pharmaceutical market. While there may be great opportunities for manufacturers and professionals in the biosimilars field, parallel concerns regarding manufacturing, clinical trials, economics, intellectual property, analytical methods, safety and efficacy arise with favorable regulatory developments.
The workshop will also be featured presentations from leading biosimilars personalities with different perspectives on the biosimilars field and will provide updates and explore potential solutions to these concerns.
Participants of the conference will be able to:
  1. Discuss on the new law and how the litigation landscape will develop
  2. Discuss the key regulatory and scientific issues of biosimilars and follow-on biologics
  3. Explain the current availability, assessing impact of biosimilars
  4. Analyze the key issues of biosimilars and follow-on biologic
  5. Compare and contrast the intellectual property issues between US Pathway and pathways in other countries, including the India Pathway
  6. Discover the key strategies for process development/manufacturing of biosimilar
  7. Understand the development and commercialization of biosimilars

SCM Pharma India 2010

Date:26 - 27 August 2010
Venue:Mumbai, India
Website:http://www.scmpharma-india.com/?utm_campaign=EVENTCALENDAR&utm_medium=EVENTLISTING&utm_source=CONFERENCEALERTSCOM
Organizer:UBM Conferences
Event Profile
Despite the healthy growth of the Indian pharma industry, intense competition, heavy price erosion and rapidly rising transportation and storage costs are rendering many businesses low margin and unsustainable! As organisations race to leverage the tools and techniques available to streamline their supply chains and reduce costs, how are you re-positioning your SCM department to deliver significant business advantage?
SCM Pharma India 2010 is the only high-level strategic conference focused on the specific supply chain management issues affecting Indian pharmaceutical companies. Over 2 intensive days you will hear in-depth case study presentations from key players in the areas of:
  • Cold chain management
  • Integrated end-to-end supply chain management
  • Partnering with 3PL & 4PL operators
  • Transportation and logistics
  • Warehousing and inventory management
  • SCM tools and technologies
  • Cold chain management
SCM Pharma India 2010 provides a unique opportunity for the whole supply chain team to get together under one roof, and investigate the challenges and opportunities associated with taking the pharma supply chain to the next level: robust, resilient, and cost-effective!
Just some of the highlights of the conference include:
  • Dr. Reddy's
  • Piramal Healthcare
  • Eli Lilly
  • USV
  • Merck Watson Pharma
  • Zydus Cadila
  • AstraZenec
  • Panacea Biotec
Web Counter: